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Abstract
Background: Viral myocarditis is a major cause of sudden unexpected death in children and young adults. Until
recently, coxsackievirus B3 (CVB3) has been the most commonly implicated virus in myocarditis. At present, no
standard diagnosis is generally accepted due to the insensitivity of traditional diagnostic tests. This has prompted
health professionals to seek new diagnostic approaches, which resulted in the emergence of new molecular
pathological tests and a more detailed immunohistochemical and histopathological analysis. When supplemented
with immunohistochemistry and molecular pathology, conventional histopathology may provide important clues
regarding myocarditis underlying etiology.
Methods: This study is based on post-mortem samples from sudden unexpected death victims and controls who
were investigated prospectively. Immunohistochemical investigations for the detection of the enteroviral capsid
protein VP1 and the characterization and quantification of myocardial inflammatory reactions as well as molecular
pathological methods for enteroviral genome detection were performed.
Results: Overall, 48 sudden unexpected death victims were enrolled. As for controls, 37 cases of unnatural traffic
accident victims were studied. Enterovirus was detected in 6 sudden unexpected death cases (12.5 %). The control
samples were completely enterovirus negative. Furthermore, the enteroviral capsid protein VP1 in the myocardium
was detected in enterovirus-positive cases revealed by means of reverse transcriptase-polymerase chain reaction
(RT-PCR). Unlike control samples, immunohistochemical investigations showed a significant presence of T and B
lymphocytes in sudden unexpected death victims.
Conclusions: Our findings demonstrate clearly a higher prevalence of viral myocarditis in cases of sudden
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Background
From a forensic point of view, sudden death is mainly
defined as rapid, unexpected and natural death [1]. Most
often, sudden unexpected death due to natural causes
results from previously unknown cardiovascular diseases
though extra cardiac causes should not be ruled out
[1,2]. Viral myocarditis, defined clinically as an inflam-
mation of the heart muscle caused by viral infection, is
an insidious disease and a major cause of sudden unex-
pected death [1-6] accounting for approximately 20% of
cases in adults under 40. More than 20 viruses have been
associated with myocarditis, causing mild to severe injury
in the myocardium with ultimate manifestation of end-
stage dilated cardiomyopathy and heart failure. Among
them, CVB3, a small nonenveloped single-stranded and
positive-sense RNA genome of the Picornaviridae family
and Enterovirus genus [7], has been implicated in 25% to
40% of acute myocarditis and dilated cardiomyopathy
cases in infants and young adolescents. Myocardial in-
flammation could be detected in 1 to 9% of routine
post-mortem examinations [6]. The clinical diagnosis of
myocarditis is made difficult by its variable and nonspe-
cific presentations [4,8-10]. Histopathology is the corner-
stone of the diagnosis. A uniform histopathological
definition for diagnosis was presented in a consensus
statement in 1987 [4,11-13]. According to Dallas criteria,
the histopathological diagnosis of myocarditis is based
on necrosis or degeneration of the myocytes (or both)
and an adjacent inflammatory infiltrate [11,12]. However,
the histopathological diagnosis of the disorder remains
difficult [14,15]. The relations between the clinical pres-
entation and the histopathological evidence of myocardi-
tis are to be determined. Fatal cases provide a unique
opportunity to study these questions as both clinical and
histopathological data are available. Furthermore, myo-
carditis may be falsely recorded as the cause of death if
no other obvious causes have been found. In this frame-
work, the current study is aimed at investigating into
how accurately viral myocarditis is involved in death
when conventional histopathology is supplemented with
immunohistochemistry and molecular pathology.
Methods
Post-mortem samples
In this study, post-mortem myocardial samples were col-
lected from November 2006 to November 2010. The
study included 48 sudden unexpected death cases with
clinically suspected inflammatory heart disease. All vic-
tims were 18 to 42-year-old males (mean age 29.8 years).
The victims’ families denied any previous health pro-
blems or coronary artery disease risk factors. The patients
were not on any medications and did not give a history of
allergy, alcohol or tobacco consumption. The autopsies
were performed at two university hospitals located on the
coast of Tunisia (Monastir and Sousse). For each sudden
unexpected death victim, two myocardial samples
(1 cm3) were taken from each lobe of the right ventricle,
the septum and the left ventricle. The post-mortem myo-
cardial samples were divided into two categories: one
fixed in formalin (neutral buffered formaldehyde 30%
diluted to 1/10) and embedded in paraffin for histopath-
ology and immunohistochemistry and one frozen and
stored at -80°C for RT-PCR. The samples were obtained
at autopsy (maximal delay of 12 hours after death). As for
controls, post-mortem myocardial samples were collected
from 37 cases of unnatural traffic accident deaths. They
were 23 to 35 years old (mean age 28.7 years) without
any known cardiac pathologies (Table 1).
The research protocol related to the current study was
referred to the Ethics and Medical Research Committees
of Farhat Hached University Hospital (Sousse) and Fat-
touma Bourguiba University Hospital (Monastir). Both
committees gave their approval. As for the samples, they
were taken in compliance with the Tunisian law (Act 91-
22; March 25th 1991) pertaining to human organ re-
moval and transplantation. An individual who has
reached the age of majority and who is mentally compe-
tent may consent to donate his or her organs for thera-
peutic or scientific purposes. Thus, an organ may be
removed from a cadaver for the above mentioned pur-
poses if the deceased individual had not made known
while alive his or her refusal to donate and if this proced-
ure was not opposed by any of the people of full legal
capacity (children, parents, spouse, siblings, legal guard-
ian). Accordingly, all samples were taken with the
informed consent of the deceased individuals’ next of kin.
Histopathology: hematoxylin–eosin staining
The post-mortem myocardial samples taken from each
sudden unexpected death victim were fixed in formalin
(neutral buffered formaldehyde 30% diluted to 1/10) for
24 hours and embedded in paraffin. The sections (5 μm)
were cut from the paraffin-embedded tissues with a
microtome. All sections were stained with hematoxylin-
eosin staining (Invitrogen: Vermont, USA) and the slides
were investigated for myocarditis [16-19].
Immunohistochemical analysis
In all cases, immunohistochemical investigations were
performed for CD3-T-lymphocytes (DAKO: Vermont,
Table 1 Epidemiological data of investigated groups
SUD victims (n= 48) Control group (n = 37)
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USA) and CD19-B-lymphocytes (DAKO: Vermont,
USA) where the average of counted cells in 20 high
power fields (hpf; 400x) was noted. The same investiga-
tions were conducted for the enteroviral capsid protein
VP1 Mab 5-D8/1 (DAKO: Vermont, USA). Tris-buffered
NaCl solution with tween 20, the target retrieval solu-
tion, serum-free protein block, antibody diluent, mayer's
hematoxylin, EnVision+ system-HRP (AEC) and glycer-
gelW mounting medium aqueous were all purchased
from DAKO (Vermont, USA). The Immunohistochem-
ical procedures included antigen exposure, blocking, in-
cubation with primary antibody, incubation with the
secondary antibody in the En-Vision detection system,
and appropriate wash between steps using Tris-buffered
saline with tween 20. All incubations were performed at
room temperature [20-23]. Briefly, paraffin-embedded
tissue sections (5 μm) were dewaxed with xylene and
rehydrated with graded ethanol. Antigen exposure was
achieved by heat in a water bath (95-99°C) mediated by
target retrieval. The endogenous peroxidase activity was
blocked with a peroxidase-blocking reagent for 15 min-
utes. The tissue sections were blocked with the protein
block for 10 minutes and then incubated with primary
antibody (appropriately diluted to 1:100-1:500 in anti-
body diluent) for 30 minutes and washed. The secondary
antibody in the En-Vision detection system is the goat
anti-mouse Ig conjugated with dextran polymer, on
which many peroxidase molecules were labeled. The sec-
tions were incubated with this reagent for 30 minutes,
washed, and then reacted with substrate chromogen for
5-10 minutes. The slides were immersed in aqueous
hematoxylin for counterstaining. The color reaction was
stopped by a wash in distilled water. Finally, the
mounted sections were examined and confirmed under
a Nikon Eclipse 50i microscope.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNA was extracted from frozen myocardial tissues using
the TRIzolWPlus RNA Purification Kit (Invitrogen: Ver-
mont, USA) according to the suppliers’ protocol. DNase
treatment during RNA purification was conducted using
PureLink™ DNase (Invitrogen: Vermont, USA) in order
to obtain DNA-free total RNA. For the detection of en-
terovirus RNA, One-step RT-PCR was performed with
primers directed to the conserved sequences in the 5'-
noncoding region of the enterovirus genome. To con-
firm that the extracted RNA contained enterovirus RNA,
a 155 bp gene fragment was amplified with a one-step
RT-PCR (Invitrogen SuperScript™ One-Step RT-PCR
with PlatinumW Taq: Vermont, USA) using 5 μl of
extracted viral RNA and two 5'-noncoding region spe-
cific primers 006 and 007 [24]. The RT-PCR was per-
formed with 25 μl 2X reaction mix (a buffer containing
0.4 mM of each dNTP, 2.4 mM MgSO4), 0.2 μM each of
sense and anti-sense primers, 1 μl enzyme mix (RT/Pla-
tinumW Taq; invitrogen: Vermont, USA), and RNase free
water up to 50 μl. The reaction was carried out with an
initial reverse transcription step at 42°C for 30 minutes
followed by PCR activation at 94°C for 5 minutes, 30
amplification cycles (94°C, 30 seconds; 42°C, 1 minute;
72°C, 2 minutes), and a final 10-minute extension at
72°C in an Eppendorf Mastercycler Thermal Cycler. The
PCR-products were run on a 2% agarose gel stained with
ethidium bromide and visualized under UV-light.
Sequencing and analysis of PCR enterovirus amplification
products
The PCR amplicons were purified using the ExoSAP-IT
– PCR Clean-Up Reagent (USBW Products from Affyme-
trix, Inc: Vermont, USA) which represents a one-step
enzymatic cleanup of PCR products. Then, they were
sequenced in forward and reverse directions with the re-
spective PCR primers. The chromatogram sequencing
files were inspected with FinchTV (version 1.4.0). The
obtained enterovirus sequences were compared to the
corresponding ones available in GenBank using the Basic
Local Alignment Search Tool in order to identify the en-
terovirus type [25,26].
Results
Histopathological investigation for the detection of
inflammatory markers and necrosis factors in the
myocardium of sudden unexpected death victims
Having investigated all the paraffin tissue blocks from 48
sudden unexpected death victims with inflammatory car-
diovascular disease suspected clinically, active myocardi-
tis was present in four of the 48 cases. Routine
histopathological examination revealed these four cases
had diffuse inflammation (Figure 1A, B, and C). The
slides from the paraffin tissue blocks from 37 cases of
unnatural traffic accident victims (control group)
showed no significant pathological findings (Figure 1D).
Immunohistochemical detection of enteroviral
capsid protein VP1, CD3-T-lymphocytes and
CD19-B-lymphocytes in the myocardium of sudden
unexpected death victims
To determine whether the enterovirus cardiac infection
was associated with a viral protein synthesis activity and
the presence of infiltrates, all the paraffin tissue blocks
taken from sudden unexpected death victims and con-
trols were examined by immunohistochemical assays
specific for the enteroviral capsid protein VP1, CD3-T-
lymphocytes and CD19-B-lymphocytes. The VP1 capsid
protein within the myocardium was detected for all the
three tested samples in six of the 48 sudden unexpected
death victims (Figure 2A, and B). The slides from the
control subjects showed a negative result with no
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significant pathological findings (Figure 2C). As shown
in figure 2 illustrating typical results obtained from
six sudden unexpected death victims, the enteroviral
capsid protein VP1 appeared to be distributed conflu-
ently. The results obtained by quantification of CD3-
T-lymphocytes and CD19-B-lymphocytes are listed in
Table 2. Unlike control samples, the immunohisto-
chemical investigations revealed a significant presence
of CD3-T-lymphocytes and CD19-B-lymphocytes in
sudden unexpected death victims having a diffuse dis-
tribution (Figure 3A and B).
Molecular identification of the enterovirus RNA by RT-PCR
and sequencing of PCR enterovirus amplification
products
In parallel, the post-mortem myocardial samples were
tested for the presence of RNA by RT-PCR using the
primers located in the 5'-noncoding region of the en-
terovirus genome. This marker was positive in at least
one of the three samples in six of the 48 tested sudden
unexpected death victims. The control samples were
negative for enterovirus. Fragments of 155 bp were seen
on agarose gel (Figure 4). The sequence analysis of
enterovirus-specific RT-PCR assays using RNA extracted
from frozen myocardial tissues confirmed the presence
of CVB3 in five cases and CVB1 in one.
Discussion
In a cohort of Tunisian sudden unexpected death vic-
tims with inflammatory cardiovascular diseases sus-
pected clinically, the enterovirus from both frozen and
formalin-fixed paraffin-embedded post-mortem myocar-
dial samples was identified in 12.5% of cases using histo-
pathology supplemented with immunohistochemistry
and molecular-pathology. These findings could have a
marked impact on the quality of future investigations in
such cases. More importantly, the present results and
the investigation methods suggested herein would enable
pathologists to better understand and elucidate the cause
of death. In this study, the positive results were con-
firmed using a variety of techniques. Frequency and
identification of infectious agents in myocarditis cases
have varied widely from 10% to 100% [10,27,28]. These
significant differences stem from several factors
BA
DC
Figure 1 Histological specimen (hematoxylin-eosin staining) from Sudden Unexpected Death victims demonstrating active
myocarditis. [1A, 1B, 1C] Areas of diffuse myocardial necrosis with large inflammatory infiltrates (arrows). [1D]Control samples (unnatural traffic
accident deaths) showing no significant pathological findings.
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including the studied sample (serum, cardiac puncture,
frozen heart tissue, formalin-fixed paraffin-embedded
myocardial samples), the methods used to detect the in-
fectious agent, result confirmation, correlation with clin-
ical and histopathological findings, and the time of
illness when the sample was collected.
Enterovirus represents the most common agent of myo-
carditis. Viral proteins are synthesized as polyprotein,
subsequently cleaved to produce the four capsid proteins
VP1 to VP4. RT-PCR as well as other techniques
revealed an association between enterovirus infection, in
particular the cardiotropic coxsackie B enterovirus, sero-
types B1–B5, and myocarditis [29]. As an enterovirus
group-specific monoclonal antibody (Mab) is now avail-
able, the demonstration of enteroviral antigens in myo-
cardium is possible [30]. In the current study, this Mab
was used to detect enteroviral antigens in post-mortem
myocardial formalin-fixed, paraffin-embedded sections.
To demonstrate the expression of CD3-T-lymphocytes
and CD19-B-lymphocytes simultaneously as inflamma-
tory markers, immunostaining was performed. In sudden
unexpected death victims, the most remarkable finding
was the significant presence of those infiltrates consist-
ing of T and B lymphocytes as compared to the control
group samples.
With regard to the time-dependent course of viral
myocarditis, as studied in the mouse model, early virus-
induced myocardial damage already takes place before
the histopathological signs of myocarditis defined by the
Dallas criteria can be observed [10,16]. Myocarditis mis-




Figure 2 Immunohistochemical detection of enteroviral capsid protein VP1 in post-mortem myocardial samples. [2A, 2B] Enteroviral
capsid protein VP1 detected inside myocytes (arrows) suggesting a confluent invasion of enterovirus. [2C] Control samples (unnatural traffic
accident victims) showing no significant pathological findings.
Table 2 Immunohistochemical and molecular-












1 + > 30 > 30 + (CVB3)
2 + > 30 27.6 + (CVB3)
3 + 23.3 > 30 + (CVB3)
4 + 24.9 > 30 + (CVB3)
5 + > 30 > 30 + (CVB1)
6 + > 30 > 30 + (CVB3)
Mean values of T and B-lymphocytes; 20 counted high power fields (HPF;
x400); and detection of enteroviral capsid protein VP1.
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overcome with a comprehensive combination of molecu-
lar pathological assays and immunohistochemical tech-
niques. This has been confirmed by our findings. All the
three samples in six of the 48 tested sudden unexpected
death victims were stained positive for the enteroviral
capsid protein VP1 and were associated with a signifi-
cant presence of T and B lymphocytes. More intriguing,
they all tested positive for enterovirus RNA by RT-PCR.
However, a higher prevalence of viral myocarditis can be
revealed by the application of a comprehensive combin-
ation of molecular pathological analysis for the detection
of enterovirus RNA from frozen heart tissues, and
immunohistochemical techniques for the detection of
the enteroviral capsid protein VP1 and both CD3-
T-lymphocytes and CD19-B-lymphocytes from formalin-
fixed, paraffin-embedded heart tissue. This is of great
importance when a routine histopathological examin-
ation alone does not yield reliable findings in heart
muscle tissue.
Conclusion
In conclusion, the present study based on sudden un-
expected death cases on the coast of Tunisia demon-
strates clearly a higher prevalence of viral myocarditis
suggesting that coxsackie B enterovirus may contribute
to myocarditis pathogenesis significantly. The combined
investigations using histopathology, molecularpathologi-
cal techniques and immunohistochemical methods were
able to reveal the causative agents of death. Prospective
murin experimental myocarditis would be desirable and
could have a marked impact on the quality of future
investigations to better understand and elucidate the




Figure 3 Immunohistochemical studies for the identification of
infected immune cells in the myocardium of sudden
unexpected death victims. [3A] Immunohistochemical labeling of
paraffin-embedded tissue sections with antibody recognizing T cell
(arrows). [3B] Immunohistochemical labeling of paraffin-embedded
tissue sections with antibody recognizing B cell (arrows).
Figure 4 Detection of Coxsackie B enterovirus RNA by RT-PCR in post-mortem myocardial samples from Sudden Unexpected Death
victims (1 and 10: molecular size marker 100-bp DNA ladder; 2: Negative control RNA extraction; 3: Negative control RT-PCR mixture;
4 to 6 and 8: Samples from coxsackie B enterovirus-positive cases; 7: Samples from a coxsackie B enterovirus-negative case; 9: A
positive control; coxsackievirus B3: 155 bp).
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